We are pleased the FDA has declared that supply of the only real, FDA-approved semaglutide medicines is resolved, affirming that Novo Nordisk is meeting or exceeding current and projected nationwide demand, Dave Moore, president of Novo Nordisk Inc., said in a statement Friday
Reading the numbers carefully The trials are not identical, so treat the gap as suggestive, not definitive
Potential Side Effects and Overlap Both medications can cause a specific set of side effects that may be intensified when used together
Changes in Energy Balance and Body Composition at Menopause: A Controlled Longitudinal Study. Annals of Internal Medicine , vol
Weight loss that depends on feeling sick, skipping meals, or being unable to eat enough protein is not the same as medically supervised fat loss with muscle preservation
IGF-1 DES Side Effect Profile DES is short-acting and 10x more potent at the receptor , but its effects are localized